CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Intravenous Dextrose Drip versus Push for Adults Experiencing Hypoglycemia: Comparative Clinical Effectiveness

Last updated: May 6, 2019
Project Number: RB1335-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the comparative clinical effectiveness and safety of dextrose 10% intravenous drip versus dextrose 50% intravenous push for adults experiencing acute hypoglycemia?

Key Message

No relevant literature was identified regarding the comparative clinical effectiveness and safety of dextrose 10% intravenous drip versus dextrose 50% intravenous push for adults experiencing acute hypoglycemia.